CL
59
3
EMR
65
-8
AMAT
49
-6
CVS
39
-11
EQIX
50
-3
AAP
12
-14
CPB
39
2
CAT
70
-9
EL
56
4
EMN
62
-3
AIZ
59
-2
A
43
-3
AMZN
50
-5
AME
65
-6
AES
55
-3
ALLE
46
-7
CNP
52
2
DD
55
-4
CHRW
73
-4
CI
52
3
CL
59
3
EMR
65
-8
AMAT
49
-6
CVS
39
-11
EQIX
50
-3
AAP
12
-14
CPB
39
2
CAT
70
-9
EL
56
4
EMN
62
-3
AIZ
59
-2
A
43
-3
AMZN
50
-5
AME
65
-6
AES
55
-3
ALLE
46
-7
CNP
52
2
DD
55
-4
CHRW
73
-4
CI
52
3
Financhill
Back

Braze, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
47

BRZE
Braze, Inc.

Last Price:
$33.15
Seasonality Move:
-12.95%
Buy
77

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$113.50
Seasonality Move:
-9.01%
Sell
47
Braze, Inc. (BRZE) is a Sell

Is Braze, Inc. a Buy, Sell or Hold?

  • The current Braze, Inc. [BRZE] share price is $33.14. The Score for BRZE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • BRZE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BRZE Stock Price Chart

What is Braze, Inc.'s stock price today?

  • The Braze, Inc. share price today is $33.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRZE is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $113.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

BRZE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.44 Buy
Relative Strength Index (14 RSI): 63.14 Buy
Chaikin Money Flow: -3212101 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.97 - 31.57) Buy
Bollinger Bands (100): (26.13 - 30.69) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 59.45 Buy
Chaikin Money Flow: -357754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 108.61) Buy
Bollinger Bands (100): (93.91 - 107.83) Buy

BRZE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.81 Buy
20-day SMA: 29.47 Buy
50-day SMA: 28.4 Buy
200-day SMA: 30.2 Buy
8-day EMA: 32.22 Buy
20-day EMA: 30.38 Buy
50-day EMA: 29.21 Buy
200-day EMA: 30.85 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.1 Buy
20-day SMA: 105.06 Buy
50-day SMA: 105.14 Buy
200-day SMA: 81.74 Buy
8-day EMA: 108.55 Buy
20-day EMA: 106.16 Buy
50-day EMA: 103.93 Buy
200-day EMA: 86.65 Buy

Braze, Inc. Earnings Growth & BRZE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.06 per share, an increase this year of $0.37 per share, and an increase next year of $0.31 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Braze, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):